Previous Article in Journal
Methamphetamine-Induced Loss of Syndecan-1 and Retinal Endothelial Integrity via the TAAR-1/MMP-9 Pathway
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Solomon et al. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404

by
Ruth Solomon
1,
Jan Pieter Hommen
2 and
Francesco Travascio
1,3,4,5,*
1
Department of Industrial and System Engineering, University of Miami, Coral Gables, FL 33146, USA
2
Department of Orthopedics, Florida International University, Miami, FL 33199, USA
3
Department of Mechanical and Aerospace Engineering, University of Miami, Coral Gables, FL 33146, USA
4
Department of Orthopaedic Surgery, University of Miami, Miami, FL 33136, USA
5
Max Biedermann Institute for Biomechanics at Mount Sinai Medical Center, Miami Beach, FL 33140, USA
*
Author to whom correspondence should be addressed.
Pathophysiology 2025, 32(3), 42; https://doi.org/10.3390/pathophysiology32030042
Submission received: 30 July 2025 / Accepted: 8 August 2025 / Published: 26 August 2025
In the original publication [1], there was a mistake in Table 1 as published. Table 1 included 2 subjects in the age range who were excluded due to age. The corrected Table 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Solomon, R.; Hommen, J.P.; Travascio, F. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404. [Google Scholar] [CrossRef] [PubMed]
Table 1. Summary of the demographic data of participants.
Table 1. Summary of the demographic data of participants.
OIC (StimuBlast®/PRP)Control
Male87
Female57
Age at Time of Surgery32.7 ± 10.532.7 ± 12.7 y.o.
Age Range18 to 50 y.o.18 to 55 y.o.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Solomon, R.; Hommen, J.P.; Travascio, F. Correction: Solomon et al. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404. Pathophysiology 2025, 32, 42. https://doi.org/10.3390/pathophysiology32030042

AMA Style

Solomon R, Hommen JP, Travascio F. Correction: Solomon et al. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404. Pathophysiology. 2025; 32(3):42. https://doi.org/10.3390/pathophysiology32030042

Chicago/Turabian Style

Solomon, Ruth, Jan Pieter Hommen, and Francesco Travascio. 2025. "Correction: Solomon et al. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404" Pathophysiology 32, no. 3: 42. https://doi.org/10.3390/pathophysiology32030042

APA Style

Solomon, R., Hommen, J. P., & Travascio, F. (2025). Correction: Solomon et al. Effects of Platelet-Rich Osteoconductive–Osteoinductive Allograft Compound on Tunnel Widening of ACL Reconstruction: A Randomized Blind Analysis Study. Pathophysiology 2022, 29, 394–404. Pathophysiology, 32(3), 42. https://doi.org/10.3390/pathophysiology32030042

Article Metrics

Back to TopTop